Clinical management of ascites and its complications

Clinics in Liver Disease

Volumn 5, Issue 3, 2001, Pages 833-850

  Wongcharatrawee, Suchat ^b   Garcia Tsao, Guadalupe ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALDOSTERONE ANTAGONIST; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFONICID; CEFOTAXIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; DIURETIC AGENT; FUROSEMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NORFLOXACIN; ORNIPRESSIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM; SPIRONOLACTONE; VASOCONSTRICTOR AGENT;

ALGORITHM; ARTERIAL BLOOD; ASCITES; BACTERIAL PERITONITIS; BLOOD VOLUME; HEPATORENAL SYNDROME; HUMAN; LIVER CIRRHOSIS; LIVER SINUSOID; LIVER TRANSPLANTATION; PARACENTESIS; PATHOPHYSIOLOGY; PERITONEUM VEIN SHUNT; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRACTICE GUIDELINE; PROGNOSIS; QUALITY OF LIFE; REVIEW; SODIUM RESTRICTION; SODIUM RETENTION; TREATMENT INDICATION;

EID: 0034849501     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70194-X     Document Type: Article

References (87)

1. Vasodilatation and sodium retention in prehepatic portal hypertension
2. Risk factors for spontaneous peritonitis in cirrhotic patients with ascites
3. Acute effects of the oral administration of midodrine, an α-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites
4. Acute hemoperitoneum after large-volume paracentesis
5. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
6. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites
7. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis
8. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage
9. Frequency of infections in cirrhotic patients presenting acute gastrointestinal hemorrhage
10. Aquaretic effect of the kappa-opiod agonist RU 51599 in cirrhotics rats with ascites and water retention
11. Long-term outcome after transjugular intrahepatic portosystemic shunt in non-transplant cirrhotics with hepatorenal syndrome: A phase II study
12. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: Effect of long-term administration of norfloxaxin
13. Clinical events after TIPS: Correlation with hemodynamics findings
14. Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis
15. Updating consensus in portal hypertension: Report of the Baveno III Consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension
16. Cefotaxime is more effective than ampicillintobramycin in cirrhotics with severe infections
17. Diuresis in the ascitic patient: A randomized controlled trial of three regimens
18. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis
19. Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis
20. The management of ascites and renal failure in cirrhosis
21. Complications of transjugular intrahepatic portosystemic shunt: A comprehensive review
22. Further evidence against the use of aminoglycosides in cirrhotic patients
23. Spontaneous bacterial peritonitis
24. Randomized trial comparing albumin, dextran-70 and polygeline in cirrhotic patients with ascites treated by paracentesis
25. Incidence, predictive factors and prognosis of the hepatorenal syndrome in cirrhosis with ascites
26. Treatment of patients with cirrhosis and refractory ascites by Le Veen shunt with titanium tip. Comparison with therapeutic paracentesis
27. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study
28. Current guidelines for pharmacotherapy of ascites associated with cirrhosis
29. Disorders of renal function in cirrhosis: Pathophysiology and clinical aspects
30. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites
31. Hyponatremia in cirrhosis: From pathogenesis to treatment
32. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis; results of double-blind, placebo-controlled trial
33. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis
34. Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients
35. Liver transplantation and renal function: Results in patients with and without hepatorenal syndrome
36. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites-A double-blind randomized trial
37. Complications after peritoneovenous shunting
38. Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels
39. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects of renal functions and vasoactive systems
40. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion
41. The effect of ciprofloxacin in the prevention of bacterial infections in patients with cirrhosis after upper gastrointestinal bleeding
42. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis
43. The effect of large volume paracentesis on plasma volume - A cause of hypovolemia?
44. Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial
45. N omega-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats
46. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis
47. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration
48. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes
49. Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis
50. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis
51. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites
52. A prospective randomized trial of ceftazidime versus nethylmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients
53. Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients
54. Effects of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis
55. Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites?
56. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis
57. Single, total paracentesis for tense ascites: Sequential hemodynamic changes and right atrial size
58. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection
59. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system
60. Fluoroquinolone resistance. Overuse of fluoroquinolones in human and veterinary medicine can breed resistance
61. Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: Role of hyperglucagonemia
62. Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites
63. Transjugular intrahepatic portosystemic shunt in the management of refractory ascites: Effect on clinical, renal, humoral and hemodynamic parameters
64. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients
65. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: Incidence and risk factors
66. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage
67. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: A consensus document
68. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis: Results of a prospective, randomized, multicenter study
69. Efficacy of ceftizoxime in the treatment of severe bacterial infections in patients with cirrhosis
70. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites
71. Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics, in cirrhosis
72. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis
73. Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patient with ascites
74. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
75. Peripheral arterial vasodilation: Determinant of functional spectrum of cirrhosis
76. Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function
77. Effect of portosystemic shunting on PgI 2 and glucagon levels in humans
78. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage
79. Transjugular intrahepatic portosystemic shunts for refractory ascites: Assessment of clinical and hormonal response and renal function
80. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis
81. Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors
82. Spontaneous bacterial peritonitis in cirrhosis: Predictive factors of infection resolution and survival of patients treated with cefotaxime
83. Randomized, multicenter, comparative study between TIPS and paracentesis with albumin in cirrhosis with refractory ascites
84. TIPS versus paracentesis in the treatment of refractory ascites: Preliminary results of a randomized controlled trial
85. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility
86. Pattern of sodium handling and its consequences in patients with preascitic cirrhosis
87. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites